African Journal of Urology (ISSN: 1110-5704, E-ISSN: 1961-9987) is a leading scholarly publication in the field of urology, published by SPRINGER from the United Kingdom. Since adopting an open access model in 2012, this journal has aimed to increase the visibility and dissemination of vital research findings across the African continent and beyond. With a current impact factor and significant standing, as denoted by its Q3 ranking in Urology for 2023, it serves as an essential platform for clinicians, researchers, and students alike. The journal's scope encapsulates all aspects of urology, fostering advancements in both clinical practices and innovative research while specifically addressing healthcare challenges relevant to African populations. As part of its commitment to accessibility and academic excellence, the journal offers full open access to its content, allowing for a broad readership and engagement with cutting-edge studies. Engage with the African Journal of Urology to contribute to and stay informed about vital developments in urological science.

Turkish Journal of Urology, published by AVES, is a distinguished academic journal dedicated to the field of urology. As an open-access journal since 2022, it aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the advancement of urological science and practice. With a notable presence in the academic community, the journal currently holds a Scopus rank of #59 out of 107 in the Medicine _ Urology category, placing it in the 45th percentile. This positions the Turkish Journal of Urology as a vital resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments and innovations in urology. Publishing from its base in Istanbul, Turkiye, the journal emphasizes accessibility and visibility, making it a powerful platform for scholarly communication in an increasingly globalized field.

CUAJ - Canadian Urological Association Journal is a premier, peer-reviewed journal dedicated to advancing the field of urology, published by the Canadian Urological Association. With its ISSN 1911-6470 and E-ISSN 1920-1214, the journal serves as a vital platform for disseminating high-quality research and clinical insights relevant to urology and oncology. Located in Canada, CUAJ is committed to publishing original research, reviews, and case studies that contribute to the scientific community's understanding of urological diseases and treatments. As of 2023, CUAJ holds a notable ranking of Q2 in Urology and Q3 in Oncology, reflecting its rigorous editorial standards and impactful contributions to the field, particularly acknowledged by its Scopus ranking as #61 in the Medicine and Urology category. Although primarily not an open-access journal, it aims to foster scholarly communication that empowers researchers, healthcare professionals, and students. With a rich history from its inception in 2007, CUAJ continues to play an integral role in shaping urological education and practice, making it an essential read for anyone involved in this dynamic field.

Advances in Urology is a premier scholarly journal published by HINDAWI LTD that has been contributing to the field of urology and obstetrics since its establishment. With an impact factor reflecting its growing influence, this Open Access journal, available since 2008, ensures that researchers and professionals can readily access cutting-edge developments in urological health, surgical techniques, and innovative treatment methodologies. Based in the United States, the journal covers a wide array of topics relevant to urology and obstetrics, maintaining a notable presence in academic rankings, with a Q2 category designation in both fields as of 2023. The journal is indexed in Scopus, ranking #54 out of 120 in Urology and #95 out of 209 in Obstetrics and Gynecology, further adding to its credibility and reach. As it converges from 2009 to 2024, Advances in Urology continues to be a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions within these critical areas of medicine.

The Journal of Clinical Urology, published by SAGE Publications Ltd, is a prominent academic platform dedicated to advancing the field of urology and surgical medicine. With an ISSN of 2051-4158 and an E-ISSN of 2051-4166, this journal has been pivotal in disseminating cutting-edge research since its inception in 2008 and is set to continue through 2024. Although categorized in the Q4 quartile for both Surgery and Urology, and positioned in the 24th and 22nd percentiles respectively according to Scopus rankings, the journal remains an essential resource for professionals, researchers, and students who seek to understand clinical developments and innovative practices in urological surgery. While the journal does not operate under an Open Access model, it provides critical insights and valuable findings that significantly impact healthcare practices and patient outcomes in the urology field.

Translational Andrology and Urology is a premier journal published by AME Publishing Company, dedicated to advancing research in the fields of reproductive medicine and urology. Established in 2012 and gaining prominence with its Q2 rankings in both the reproductive medicine and urology categories as of 2023, this journal serves as a vital platform for disseminating groundbreaking studies and clinical advancements. With an ISSN of 2223-4683 and an E-ISSN of 2223-4691, it is indexed in Scopus, standing at a distinguished rank of #40/120 in Urology and #33/90 in Reproductive Medicine. Located in Hong Kong, the journal reflects a commitment to open access and international collaboration, providing researchers, professionals, and students with critical insights and updates in these dynamic fields. As a leading resource, Translational Andrology and Urology invites contributions that explore innovative approaches that can enhance patient care and clinical practices.

European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.

Welcome to the Scandinavian Journal of Urology, a dynamic platform dedicated to advancing the fields of urology and nephrology. Published by Medical Journal Sweden AB and located in the United Kingdom, this esteemed journal features open access options that enhance the accessibility of cutting-edge research to a global audience. With an impressive impact factor and a respectable position in Scopus rankings—#55/120 in Urology and #45/81 in Nephrology—the journal occupies a vital niche for researchers, clinicians, and students eager to share and engage with pioneering studies from 2013 to 2024. As part of the Q2 quartile in both urology and nephrology categories, the Scandinavian Journal of Urology plays a crucial role in informing and shaping contemporary clinical practices and research directions. Join us in exploring the latest developments and evidence-based findings in these essential areas of medical science.

European Urology Focus is a premier journal published by Elsevier, dedicated to advancing the field of urology. With its inception dating back to 2015 and a convergence period extending through 2024, this journal has rapidly established itself as a leading platform within the medical community, boasting an impressive Scopus ranking of #5 out of 120 in Urology, placing it in the 96th percentile. The journal is recognized for its impactful contributions to urological research, and it is classified in the prestigious Q1 category for Urology in 2023. Based in the Netherlands, European Urology Focus prioritizes innovative research, reviews, and clinical observations, catering not only to seasoned professionals but also to emerging scholars and practitioners in the field. While traditionally a subscription-based journal, it offers flexible access options tailored for its diverse readership. With a commitment to enhancing knowledge and improving patient outcomes in urological health, European Urology Focus stands as a vital resource for those engaged in this essential area of medicine.

European Urology Open Science is a premier open-access journal dedicated to advancing the field of urology through publishing high-quality, peer-reviewed research. Published by ELSEVIER in the Netherlands, this journal is recognized for its significant contribution to the medical community, boasting an impressive Q1 ranking in Urology for 2023, indicative of its influence and the quality of research it disseminates. With a focus on innovative studies and interdisciplinary approaches, the European Urology Open Science plays a pivotal role in fostering knowledge exchange and promoting clinical best practices. Researchers, professionals, and students alike benefit from its accessible research format, facilitating a broader dissemination of urological advancements. This journal embraces the Open Access model, ensuring that pioneering findings are readily available to the global scientific community, further enhancing collaboration and knowledge sharing within the field.